ArticleJournal of experimental & clinical cancer research : CR2025

The de novo DNA methyltransferase 3B is a novel epigenetic regulator of MYC in multiple myeloma, representing a promising therapeutic target to counter relapse.

Catharina Muylaert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.